Lista de obras -

A framework for evaluating markers used to select patient treatment

artículo científico publicado en 2013

Accommodating Covariates in ROC Analysis

artículo científico publicado en 2009

Adjusting for Covariate Effects in Biomarker Studies Using the Subject-specfic Threshold Roc Curve ⬇️

doctoral thesis by Holly Janes, University of Washington, 2005

Adjusting for covariate effects on classification accuracy using the covariate-adjusted receiver operating characteristic curve

artículo científico publicado en 2009

Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial

artículo científico publicado en 2014

Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk

scientific article published on 01 November 2019

Assessing the Clinical Impact of Risk Prediction Models With Decision Curves: Guidance for Correct Interpretation and Appropriate Use.

artículo científico publicado en 2016

Assessing the value of risk predictions by using risk stratification tables

artículo científico publicado en 2008

Assessing treatment-selection markers using a potential outcomes framework

artículo científico publicado en 2012

Case-crossover analyses of air pollution exposure data: referent selection strategies and their implications for bias

artículo científico publicado en 2005

Case-only approach to identifying markers predicting treatment effects on the relative risk scale ⬇️

artículo científico publicado en 2017

Characterizing expected benefits of biomarkers in treatment selection

artículo científico publicado en 2014

Combining biomarkers to optimize patient treatment recommendations

artículo científico publicado en 2014

Commentary: Reporting standards are needed for evaluations of risk reclassification ⬇️

artículo científico publicado el 13 de mayo de 2011

Cox models for ecologic time-series data?

artículo científico publicado en 2006

Designing a study to evaluate the benefit of a biomarker for selecting patient treatment

artículo científico publicado en 2015

Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility?

artículo científico publicado en 2016

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials

artículo científico publicado en 2015

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

artículo científico publicado en 2020

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

artículo científico publicado en 2021

Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine

artículo científico publicado en 2013

Estimation and Comparison of Receiver Operating Characteristic Curves

artículo científico publicado en 2009

Evaluating the impact of policies recommending PrEP to subpopulations of men and transgender women who have sex with men based on demographic and behavioral risk factors

artículo científico publicado en 2019

FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial

artículo científico publicado en 2014

Fine particulate matter and mortality: a comparison of the six cities and American Cancer Society cohorts with a medicare cohort

artículo científico publicado en 2008

First things first: risk model performance metrics should reflect the clinical application

artículo científico publicado en 2017

HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders

artículo científico publicado en 2015

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis

artículo científico publicado en 2008

Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?

artículo científico publicado en 2013

Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?

artículo científico publicado en 2013

Identifying post-menopausal women at elevated risk for epithelial ovarian cancer

artículo científico publicado en 2015

Impact of herpes simplex virus type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the Step study)

artículo científico publicado en 2011

In pursuit of an HIV vaccine: designing efficacy trials in the context of partially effective nonvaccine prevention modalities

scientific article published on 25 June 2013

Insights into latent class analysis of diagnostic test performance

artículo científico publicado en 2006

Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans

scientific article published on 30 January 2020

Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker

artículo científico publicado en 2004

MRKAd5 HIV-1 Gag/Pol/Nef vaccine-induced T-cell responses inadequately predict distance of breakthrough HIV-1 sequences to the vaccine or viral load

artículo científico publicado en 2012

Matching in studies of classification accuracy: implications for analysis, efficiency, and assessment of incremental value

artículo científico publicado en 2007

Measuring the Performance of Markers for Guiding Treatment Decisions ⬇️

artículo científico publicado el 15 de febrero de 2011

Net reclassification indices for evaluating risk prediction instruments: a critical review

scientific article published on January 2014

Net risk reclassification p values: valid or misleading?

artículo científico publicado en 2014

New clinical trial designs for HIV vaccine evaluation

artículo científico publicado en 2013

On quantifying the magnitude of confounding

artículo científico publicado en 2010

Overlap bias in the case-crossover design, with application to air pollution exposures

artículo científico publicado en 2005

Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design

artículo científico publicado en 2008

Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trials

artículo científico

Re: "Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance: the Tehran Lipid and Glucose Study".

artículo científico publicado en 2013

Rejoinder: Combining biomarkers to optimize patient treatment recommendations

artículo científico publicado en 2014

Reply to A.J. Vickers et al.

artículo científico publicado en 2016

Selection of HIV vaccine candidates for concurrent testing in an efficacy trial

artículo científico publicado en 2016

Statistical analysis of air pollution panel studies: an illustration

artículo científico publicado en 2008

Statistical methods for down-selection of treatment regimens based on multiple endpoints, with application to HIV vaccine trials

artículo científico publicado en 2016

Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration

artículo científico publicado en 2011

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration.

artículo científico publicado en 2011

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration

artículo científico publicado en 2011

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration

The Fundamental Difficulty With Evaluating the Accuracy of Biomarkers for Guiding Treatment

artículo científico publicado en 2015

Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies

artículo científico publicado en 2009

Trends in air pollution and mortality: an approach to the assessment of unmeasured confounding

artículo científico publicado en 2007

Understanding HIV epidemics: aggregate viral load metrics and 'smoking guns'.

artículo científico publicado en 2013

Use of placebos in Phase 1 preventive HIV vaccine clinical trials

artículo científico publicado en 2014

Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection

artículo científico publicado en 2013

Lista de obras de

A framework for evaluating markers used to select patient treatment

Accommodating Covariates in ROC Analysis

Adjusting for Covariate Effects in Biomarker Studies Using the Subject-specfic Threshold Roc Curve ⬇️

Adjusting for covariate effects on classification accuracy using the covariate-adjusted receiver operating characteristic curve

Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial

Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk

Assessing the Clinical Impact of Risk Prediction Models With Decision Curves: Guidance for Correct Interpretation and Appropriate Use.

Assessing the value of risk predictions by using risk stratification tables

Assessing treatment-selection markers using a potential outcomes framework

Case-crossover analyses of air pollution exposure data: referent selection strategies and their implications for bias

Case-only approach to identifying markers predicting treatment effects on the relative risk scale ⬇️

Characterizing expected benefits of biomarkers in treatment selection

Combining biomarkers to optimize patient treatment recommendations

Commentary: Reporting standards are needed for evaluations of risk reclassification ⬇️

Cox models for ecologic time-series data?

Designing a study to evaluate the benefit of a biomarker for selecting patient treatment

Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility?

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine

Estimation and Comparison of Receiver Operating Characteristic Curves

Evaluating the impact of policies recommending PrEP to subpopulations of men and transgender women who have sex with men based on demographic and behavioral risk factors

FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial

Fine particulate matter and mortality: a comparison of the six cities and American Cancer Society cohorts with a medicare cohort

First things first: risk model performance metrics should reflect the clinical application

HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis

Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?

Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?

Identifying post-menopausal women at elevated risk for epithelial ovarian cancer

Impact of herpes simplex virus type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the Step study)

In pursuit of an HIV vaccine: designing efficacy trials in the context of partially effective nonvaccine prevention modalities

Insights into latent class analysis of diagnostic test performance

Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans

Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker

MRKAd5 HIV-1 Gag/Pol/Nef vaccine-induced T-cell responses inadequately predict distance of breakthrough HIV-1 sequences to the vaccine or viral load

Matching in studies of classification accuracy: implications for analysis, efficiency, and assessment of incremental value

Measuring the Performance of Markers for Guiding Treatment Decisions ⬇️

Net reclassification indices for evaluating risk prediction instruments: a critical review

Net risk reclassification p values: valid or misleading?

New clinical trial designs for HIV vaccine evaluation

On quantifying the magnitude of confounding

Overlap bias in the case-crossover design, with application to air pollution exposures

Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design

Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trials

Re: "Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance: the Tehran Lipid and Glucose Study".

Rejoinder: Combining biomarkers to optimize patient treatment recommendations

Reply to A.J. Vickers et al.

Selection of HIV vaccine candidates for concurrent testing in an efficacy trial

Statistical analysis of air pollution panel studies: an illustration

Statistical methods for down-selection of treatment regimens based on multiple endpoints, with application to HIV vaccine trials

Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration.

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration

The Fundamental Difficulty With Evaluating the Accuracy of Biomarkers for Guiding Treatment

Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies

Trends in air pollution and mortality: an approach to the assessment of unmeasured confounding

Understanding HIV epidemics: aggregate viral load metrics and 'smoking guns'.

Use of placebos in Phase 1 preventive HIV vaccine clinical trials

Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection